Today's Top Health News Story

Roche sues U.S. executives in fight over diabetes test strips

ZURICH (Reuters) - Roche is seeking tens of millions of dollars in damages and compensation in a U.S. lawsuit against former executives of a Utah-based company, the Swiss drugmaker's latest case targeting what it calls fraudulent schemes involving its diabetes test strips. Learn More


More Top Health Stories

U.S. jury hears more evidence as second phase of Roundup cancer trial begins

SAN FRANCISCO (Reuters) - A lawyer for a man who sued Bayer AG unit Monsanto after developing cancer on Wednesday told a jury about the company's alleged efforts to influence scientists and regulators, a day after the jury found Bayer's glyphosate-based weed killer Roundup to have caused the man's disease. More »


Jury finding upends Bayer's Roundup defense strategy: experts

NEW YORK (Reuters) - Bayer AG had hoped a new trial strategy focusing jurors on scientific evidence could stem a burgeoning tide of U.S. lawsuits over its glyphosate-based weed killer Roundup, but a second jury finding on Tuesday that the product caused cancer has narrowed the company's options, some legal experts said. More »


Congo Ebola outbreak spreads to city of Bunia

GOMA, Democratic Republic of Congo (Reuters) - Health authorities in Democratic Republic of Congo have confirmed a case of Ebola in another city of close to 1 million people, the health ministry said on Wednesday. More »


Piles of pigs: Swine fever outbreaks go unreported in rural China

BAODING, China (Reuters) - When pigs on the Xinda Husbandry Co. Ltd breeding farm in northern China began dying in growing numbers in early January, it looked increasingly likely that the farm had been struck by the much feared African swine fever, an incurable disease that has spread rapidly across the country since last year. More »


Jazz Pharma's sleep disorder treatment gets FDA nod

(Reuters) - The U.S. Food and Drug Administration approved Jazz Pharmaceuticals Plc's treatment for patients with a form of sleep disorder, the company said on Wednesday. More »


Novo Nordisk submits diabetes pill for U.S. approval

COPENHAGEN (Reuters) - Novo Nordisk has submitted its oral semaglutide drug, a pill it hopes will transform the diabetes market, for approval in the United States. More »


FDA allows sale of certain blood pressure drugs amid shortage

(Reuters) - The U.S. Food and Drug Administration on Wednesday said it will temporarily allow certain manufacturers to sell blood pressure medications containing specified levels of a probable cancer-causing impurity in order to maintain adequate supplies of the drug. More »


Study finds key details about 'punch drunk syndrome' and Alzheimer's

LONDON (Reuters) - Scientists studying damaged brains of boxers and other sports people have found key details about a head injury-linked disease called "punch drunk syndrome" that could help the development of new diagnostics and treatments for Alzheimer's. More »


With ADHD, amphetamine has double the psychosis risk of methylphenidate

(Reuters Health) - Children and young adults with attention deficit-hyperactivity disorder (ADHD) who are treated with the stimulants amphetamine or methylphenidate face a small but significant risk of developing psychosis, with amphetamine products twice as likely to spark at problem, researchers say. More »


News, Photo and Web Search